A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.
Primary Sponsor
Trans-Tasman Radiation Oncology Group (TROG)
Clinical Trial Registration
Related Post
6 November, 2025
SUPREMO trial findings signal change in breast cancer treatment
LATEST NEWS: 6 November 2025 Radiotherapy can be safely
23 October, 2025
TROG collaboration sees international skin cancer trial open in Australia
LATEST NEWS: 23 October 2025 TROG Cancer Research has